Previous 10 | Next 10 |
Penny Stocks To Watch This Month Trading penny stocks is easy. You just find some letters, pull up the order-entry ticket, buy, sell, and profit, right? While the process of actually buying penny stocks is simple, the strategy isn’t quite as easy. Anyone can get lucky trading penny ...
PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual G...
Company to Present Twirla ® Commercial Plan Webcast Scheduled from 11:00 am – 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will host a virtual Investor/Ana...
Visit BirthControlDoneMyWay.com to learn more about some of the many available contraceptive options I’m So Done is a national unbranded campaign intended to enhance the birth control conversation for women Encourage education on contraceptive care options Facilitate...
Agile Therapeutics (AGRX) struggled for years to get their once-weekly contraceptive patch, Twirla, approved by the FDA. Twirla received two CRLs from the FDA, which pummeled the share price into penny stock status, and investors' sentiment was abysmal. For two years, it looked as if the FDA w...
Where Do You Stand On These Penny Stocks Right Now? Penny stocks are well-known for their ability to breakout hugely in short timeframes. That’s the mystifying draw that brings traders to focus on stocks under $5. No matter who you talk to in the stock market today, everyone has the s...
PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner, MD, MBA, to the position of Chief Medical Officer. Dr. Korner is a board-certified obstetrician a...
Gainers: Midatech Pharma (NASDAQ: MTP ) +59% . More news on: Midatech Pharma plc, Mesoblast Limited, Sky Solar Holdings, Ltd., Stocks on the move, , Read more ...
Agile Therapeutics ( AGRX -3.5% ) reports Q2 net loss was $10.8M or EPS loss of $0.12 vs. net loss of $3.5M, or EPS loss of $0.08 in Q2 2019. More news on: Agile Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...
Agile Therapeutics, Inc. (AGRX) Q2 2020 Earnings Conference Call August 11, 2020 16:30 ET Company Participants Matthew Riley - Investor Relations Alfred Altomari - Chairman, President & Chief Executive Officer Dennis Reilly - Senior Vice President & Chief Financial Office...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
OTCMKTS Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...